{"organizations": [], "uuid": "254c2db2c65fccc772fed205cca4b264665dfb9a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180302.html", "section_title": "Archive News &amp; Video for Friday, 02 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zhongyuan-union-cell-gene-engineer/brief-zhongyuan-union-cell-gene-engineering-to-sell-its-entire-67-pct-stake-in-pharma-tech-firm-for-60-mln-yuan-idUSL4N1QK470", "country": "US", "domain_rank": 408, "title": "BRIEF-Zhongyuan Union Cell & Gene Engineering to sell its entire 67 pct stake in pharma tech firm for 60 mln yuan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.196, "site_type": "news", "published": "2018-03-02T18:58:00.000+02:00", "replies_count": 0, "uuid": "254c2db2c65fccc772fed205cca4b264665dfb9a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zhongyuan-union-cell-gene-engineer/brief-zhongyuan-union-cell-gene-engineering-to-sell-its-entire-67-pct-stake-in-pharma-tech-firm-for-60-mln-yuan-idUSL4N1QK470", "ord_in_thread": 0, "title": "BRIEF-Zhongyuan Union Cell & Gene Engineering to sell its entire 67 pct stake in pharma tech firm for 60 mln yuan", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-zhongyuan union cell & gene engineering", "sentiment": "negative"}, {"name": "reuters) - zhongyuan union cell & gene engineering corp ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 2 (Reuters) - Zhongyuan Union Cell & Gene Engineering Corp Ltd :\n* Says it plans to sell its entire 67 percent stake in a Zhejiang-based pharma tech firm for 60 million yuan\nSource text in Chinese: goo.gl/UBgokz\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/UBgokz", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-02T18:58:00.000+02:00", "crawled": "2018-03-03T17:38:13.008+02:00", "highlightTitle": ""}